XCUR实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (2 May 2024 @ 04:00):

Exicure, Inc., a biotechnology company, develops therapies for neurological disorders and hair loss based on its proprietary spherical nucleic acid (SNA) technology...

Stats
今日成交量	4 489.00
平均成交量	224 290
市值	4.41M
EPS	$0 ( 2024-04-30 )
下一个收益日期	( $0 ) 2024-07-12
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0.290
ATR14	$0.00600 (1.18%)

Insider Trading

Date	Person	Action	Amount	type
2024-02-16	Miller Josh	Sell	46	Common Stock
2024-02-29	Dgp Co., Ltd.	Sell	3 400 000	Common Stock
2023-11-16	Miller Josh	Sell	38	Common Stock
2023-09-26	Eom Minhee	Buy	0
2023-08-21	Ko Hyuk Joon	Buy	0

INSIDER POWER
-67.08
Last 81 transactions
Buy: 16 542 799 \| Sell: 13 981 621

Exicure Inc 相关性

10 最正相关
PAIC	0.95
SVAC	0.903
RMRM	0.869
TLGT	0.853
GAINL	0.846
ISNS	0.831
BBCP	0.804

10 最负相关
NETE	-0.938
RAVN	-0.905
BOCH	-0.904
MMAC	-0.899
AMRB	-0.87
SHSP	-0.865

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Exicure Inc 财务报表

Annual	2022
营收:	$28.83M
毛利润:	$26.97M (93.56 %)
EPS:	$-0.560

FY	2022
营收:	$28.83M
毛利润:	$26.97M (93.56 %)
EPS:	$-0.560

FY	2021
营收:	$0.00
毛利润:	$0.00 (0.00 %)
EPS:	$-22.05

FY	2020
营收:	$16.61M
毛利润:	$16.61 (0.00 %)
EPS:	$-8.49

Financial Reports:

No articles found.

Exicure Inc

Exicure, Inc., a biotechnology company, develops therapies for neurological disorders and hair loss based on its proprietary spherical nucleic acid (SNA) technology. Its lead program candidate includes SCN9A that is in preclinical studies for neuropathic and chronic pain. The company has a collaboration, option, and license agreement with AbbVie Inc. to develop SNA-based treatments for hair loss disorders; and collaboration agreement with Ipsen S.A. to research, develop, and commercialize novel spherical nucleic acids for Huntington's disease and Angelman syndrome. Exicure, Inc. was founded in 2011 and is headquartered in Chicago, Illinois.